89zr-panitumumab pet imaging for preoperative assessment of ameloblastoma in a pdx model

HIGHLIGHTS

  • who: Logan D. Stone from the DepartmentUniversity of have published the Article: 89Zr-panitumumab PET imaging for preoperative assessment of ameloblastoma in a PDX model, in the Journal: Scientific Reports Scientific Reports of 20/02/2022
  • what: Our data have shown that radiolabeled anti-EGFR antibody, 89Zr-panitumumab, can be used to effectively identify ameloblastoma tumor tissue in_vivo.
  • how: During the study period patients were identified with a diagnosis of primary or recur- | Vol.(1234567890) 1219187 | Antibodies and reagents.

SUMMARY

    Over 30% of the total 89Zrpanitumumab added was bound . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?